These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

774 related items for PubMed ID: 15317888

  • 1. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
    Zou S, Dodd RY, Stramer SL, Strong DM, Tissue Safety Study Group.
    N Engl J Med; 2004 Aug 19; 351(8):751-9. PubMed ID: 15317888
    [Abstract] [Full Text] [Related]

  • 2. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.
    Transfusion; 2009 Jun 19; 49(6):1115-25. PubMed ID: 19309474
    [Abstract] [Full Text] [Related]

  • 3. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.
    Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ.
    N Engl J Med; 1996 Jun 27; 334(26):1685-90. PubMed ID: 8637512
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
    El-Hazmi MM.
    Saudi Med J; 2004 Jan 27; 25(1):26-33. PubMed ID: 14758374
    [Abstract] [Full Text] [Related]

  • 5. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP, National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group.
    N Engl J Med; 2004 Aug 19; 351(8):760-8. PubMed ID: 15317889
    [Abstract] [Full Text] [Related]

  • 6. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, Hone DE, O'Brien SF, Sher G.
    CMAJ; 2003 Oct 14; 169(8):767-73. PubMed ID: 14557314
    [Abstract] [Full Text] [Related]

  • 7. The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia.
    Yao F, Seed C, Farrugia A, Morgan D, Cordner S, Wood D, Zheng MH.
    Am J Transplant; 2007 Dec 14; 7(12):2723-6. PubMed ID: 17983391
    [Abstract] [Full Text] [Related]

  • 8. Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses.
    Candotti D, Mundy C, Kadewele G, Nkhoma W, Bates I, Allain JP.
    J Med Virol; 2001 Sep 14; 65(1):1-5. PubMed ID: 11505436
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
    Matee MI, Lyamuya EF, Mbena EC, Magessa PM, Sufi J, Marwa GJ, Mwasulama OJ, Mbwana J.
    East Afr Med J; 1999 Mar 14; 76(3):167-71. PubMed ID: 10442119
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR, Kiely P, Keller AJ.
    Intern Med J; 2005 Oct 14; 35(10):592-8. PubMed ID: 16207258
    [Abstract] [Full Text] [Related]

  • 12. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing.
    Zou S, Dorsey KA, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY, Stramer SL.
    Transfusion; 2010 Jul 14; 50(7):1495-504. PubMed ID: 20345570
    [Abstract] [Full Text] [Related]

  • 13. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M, Règine V, Piccinini V, Vulcano F, Giampaolo A, Hassan HJ.
    Transfusion; 2005 Oct 14; 45(10):1670-5. PubMed ID: 16181219
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ, German Red Cross NAT Study Group.
    Transfusion; 2008 Aug 14; 48(8):1558-66. PubMed ID: 18466173
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of viral markers among first-time Arab blood donors in Kuwait.
    Ameen R, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, Al-Hamdan S, Al-Bashir A.
    Transfusion; 2005 Dec 14; 45(12):1973-80. PubMed ID: 16371052
    [Abstract] [Full Text] [Related]

  • 18. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR, SIMTI Research Group.
    Transfusion; 2008 Oct 14; 48(10):2205-13. PubMed ID: 18631163
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study.
    Zou S, Musavi F, Notari EP, Fujii KE, Dodd RY, ARCNET Study Group.
    Transfusion; 2005 Oct 14; 45(10):1593-600. PubMed ID: 16181210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.